Adenocarcinoma of the Appendix - 23 Studies Found
| Active, not recruiting |
: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers : Advanced GI Cancer : 2014-10-15 : Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14 |
| Active, not recruiting |
: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer :
|
| Withdrawn |
: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer :
|
| Terminated |
: Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery :
|
| Withdrawn |
: Research Study in Patients With Advanced Ovarian Epithelial Cancer :
|
| Active, not recruiting |
: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer :
: |
| Terminated |
: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer :
|
| Completed |
: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer :
: |
| Active, not recruiting |
: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer :
|
| Completed |
: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer :
|